Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	biotin binding	ACACA ACACB HLCS	3.58e-06	6	114	3	GO:0009374
GeneOntologyMolecularFunction	acetyl-CoA carboxylase activity	ACACA ACACB	3.23e-05	2	114	2	GO:0003989
GeneOntologyBiologicalProcess	regulation of tube diameter	HIF1A DRD1 HTR2C BBS2 ITGA1 ITGA9 TGFBR3 AHR	1.78e-05	202	115	8	GO:0035296
GeneOntologyBiologicalProcess	blood vessel diameter maintenance	HIF1A DRD1 HTR2C BBS2 ITGA1 ITGA9 TGFBR3 AHR	1.78e-05	202	115	8	GO:0097746
GeneOntologyBiologicalProcess	regulation of tube size	HIF1A DRD1 HTR2C BBS2 ITGA1 ITGA9 TGFBR3 AHR	1.84e-05	203	115	8	GO:0035150
GeneOntologyBiologicalProcess	malonyl-CoA biosynthetic process	ACACA ACACB	3.08e-05	2	115	2	GO:2001295
GeneOntologyBiologicalProcess	vasoconstriction	HIF1A DRD1 HTR2C BBS2 ITGA9 AHR	6.01e-05	121	115	6	GO:0042310
Domain	ACC_central	ACACA ACACB	3.82e-05	2	116	2	PF08326
Domain	AcCoA_COase_cen	ACACA ACACB	3.82e-05	2	116	2	IPR013537
Domain	HLH	TFEC HIF1A MLX USF3 AHR NCOA1	6.71e-05	111	116	6	PF00010
Domain	HLH	TFEC HIF1A MLX USF3 AHR NCOA1	8.58e-05	116	116	6	SM00353
Domain	BHLH	TFEC HIF1A MLX USF3 AHR NCOA1	9.00e-05	117	116	6	PS50888
Domain	bHLH_dom	TFEC HIF1A MLX USF3 AHR NCOA1	9.43e-05	118	116	6	IPR011598
Domain	Ubiquitin_3	USP11 USP32	2.28e-04	4	116	2	PF14836
Domain	Ub_USP-typ	USP11 USP32	2.28e-04	4	116	2	IPR028135
Domain	Carboxyl_trans	ACACA ACACB	2.28e-04	4	116	2	PF01039
Domain	COA_CT_CTER	ACACA ACACB	2.28e-04	4	116	2	PS50989
Domain	COA_CT_NTER	ACACA ACACB	2.28e-04	4	116	2	PS50980
Domain	COA_CT_N	ACACA ACACB	2.28e-04	4	116	2	IPR011762
Domain	COA_CT_C	ACACA ACACB	2.28e-04	4	116	2	IPR011763
Domain	Carboxyl_trans	ACACA ACACB	2.28e-04	4	116	2	IPR000022
Domain	Biotin_BS	ACACA ACACB	3.78e-04	5	116	2	IPR001882
Domain	Biotin_COase_C	ACACA ACACB	3.78e-04	5	116	2	IPR005482
Domain	BC	ACACA ACACB	3.78e-04	5	116	2	PS50979
Domain	Biotin_carb_C	ACACA ACACB	3.78e-04	5	116	2	SM00878
Domain	Biotin_carb_C	ACACA ACACB	3.78e-04	5	116	2	PF02785
Domain	Biotin_carboxylation_dom	ACACA ACACB	3.78e-04	5	116	2	IPR011764
Domain	CPSASE_1	ACACA ACACB	3.78e-04	5	116	2	PS00866
Domain	BIOTIN	ACACA ACACB	3.78e-04	5	116	2	PS00188
Domain	FG-GAP	BBS2 ITGA1 ITGA9	4.30e-04	24	116	3	PF01839
Domain	FG-GAP	BBS2 ITGA1 ITGA9	4.30e-04	24	116	3	IPR013517
Domain	PAS	HIF1A AHR NCOA1	4.86e-04	25	116	3	PF00989
Domain	PAS_fold	HIF1A AHR NCOA1	4.86e-04	25	116	3	IPR013767
Domain	DUSP	USP11 USP32	5.64e-04	6	116	2	PF06337
Domain	Rudment_hybrid_motif	ACACA ACACB	5.64e-04	6	116	2	IPR011054
Domain	DUSP	USP11 USP32	5.64e-04	6	116	2	SM00695
Domain	CPSASE_2	ACACA ACACB	5.64e-04	6	116	2	PS00867
Domain	USP_CS	USP11 USP16 USP6 USP32	7.57e-04	66	116	4	IPR018200
Domain	DUSP	USP11 USP32	7.87e-04	7	116	2	PS51283
Domain	CbamoylP_synth_lsu-like_ATP-bd	ACACA ACACB	7.87e-04	7	116	2	IPR005479
Domain	BC-like_N	ACACA ACACB	7.87e-04	7	116	2	IPR005481
Domain	-	USP11 USP32	7.87e-04	7	116	2	3.30.2230.10
Domain	CPSase_L_D2	ACACA ACACB	7.87e-04	7	116	2	PF02786
Domain	Biotin_carb_N	ACACA ACACB	7.87e-04	7	116	2	PF00289
Domain	Pept_C19_DUSP	USP11 USP32	7.87e-04	7	116	2	IPR006615
Domain	USP_1	USP11 USP16 USP6 USP32	9.45e-04	70	116	4	PS00972
Domain	UCH	USP11 USP16 USP6 USP32	9.96e-04	71	116	4	PF00443
Domain	USP_2	USP11 USP16 USP6 USP32	9.96e-04	71	116	4	PS00973
Domain	PAS	HIF1A AHR NCOA1	1.02e-03	32	116	3	SM00091
Domain	USP_3	USP11 USP16 USP6 USP32	1.05e-03	72	116	4	PS50235
Domain	USP_dom	USP11 USP16 USP6 USP32	1.05e-03	72	116	4	IPR028889
Domain	Peptidase_C19_UCH	USP11 USP16 USP6 USP32	1.05e-03	72	116	4	IPR001394
Domain	PAS	HIF1A AHR NCOA1	1.21e-03	34	116	3	PS50112
Domain	PAS	HIF1A AHR NCOA1	1.21e-03	34	116	3	IPR000014
Domain	Biotin_lipoyl	ACACA ACACB	1.34e-03	9	116	2	PF00364
Domain	BIOTINYL_LIPOYL	ACACA ACACB	1.67e-03	10	116	2	PS50968
Domain	Biotin_lipoyl	ACACA ACACB	1.67e-03	10	116	2	IPR000089
Domain	Single_hybrid_motif	ACACA ACACB	2.42e-03	12	116	2	IPR011053
Domain	-	ACACA ACACB	2.85e-03	13	116	2	3.40.50.20
Domain	ATP_GRASP	ACACA ACACB	3.31e-03	14	116	2	PS50975
Domain	ATP-grasp	ACACA ACACB	3.31e-03	14	116	2	IPR011761
Domain	PreATP-grasp_dom	ACACA ACACB	3.31e-03	14	116	2	IPR016185
Domain	-	ACACA ACACB	3.81e-03	15	116	2	3.30.1490.20
Domain	Integrin_alpha_C_CS	ITGA1 ITGA9	4.34e-03	16	116	2	IPR018184
Domain	-	TFEC MLX AHR NCOA1	4.76e-03	109	116	4	4.10.280.10
Domain	-	SEMA4B BBS2 MAPK8IP3 PLXNA4 NUP133 CFAP57 WDR13	4.78e-03	333	116	7	2.130.10.10
Domain	Aminotran_1_2	GOT1L1 KYAT3	4.89e-03	17	116	2	PF00155
Domain	Aminotransferase_I/II	GOT1L1 KYAT3	4.89e-03	17	116	2	IPR004839
Domain	WD40/YVTN_repeat-like_dom	SEMA4B BBS2 MAPK8IP3 PLXNA4 NUP133 CFAP57 WDR13	4.94e-03	335	116	7	IPR015943
Domain	Integrin_alpha-2	ITGA1 ITGA9	5.48e-03	18	116	2	IPR013649
Domain	ATP_grasp_subdomain_1	ACACA ACACB	5.48e-03	18	116	2	IPR013815
Domain	-	ACACA ACACB	5.48e-03	18	116	2	3.30.470.20
Domain	INTEGRIN_ALPHA	ITGA1 ITGA9	5.48e-03	18	116	2	PS00242
Domain	Integrin_alpha2	ITGA1 ITGA9	5.48e-03	18	116	2	PF08441
Domain	Integrin_alpha	ITGA1 ITGA9	5.48e-03	18	116	2	IPR000413
Domain	Int_alpha	ITGA1 ITGA9	6.10e-03	19	116	2	SM00191
Domain	Int_alpha_beta-p	ITGA1 ITGA9	6.10e-03	19	116	2	IPR013519
Pathway	REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION	ACACA ACACB MLX	1.20e-05	8	86	3	M26991
Pathway	WP_BIOTIN_METABOLISM_INCLUDING_IMDS	ACACA ACACB HLCS	1.79e-05	9	86	3	M40064
Pathway	REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM	ACACA ACACB HLCS	3.49e-05	11	86	3	M27086
Pathway	REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM	ACACA ACACB HLCS	3.49e-05	11	86	3	MM14764
Pathway	WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY	HIF1A ACACA ACACB	2.32e-04	20	86	3	M39751
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ACACA ACACB NACC1 CARMIL1 HLCS TACC2 LRRC59 BTAF1 USP16 RBM39 PHC3 ARID2 NUP133 MACF1	3.27e-06	934	117	14	33916271
Pubmed	USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.	USP6 USP32	1.12e-05	2	117	2	20549504
Pubmed	Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation.	ACACA ACACB	1.12e-05	2	117	2	24944901
Pubmed	Complex recombination with deletion in the F8 and duplication in the TMLHE mediated by int22h copies during early embryogenesis.	F8 TMLHE	1.12e-05	2	117	2	28492696
Pubmed	Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.	ACACA ACACB	1.12e-05	2	117	2	20139635
Pubmed	Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.	ACACA ACACB	1.12e-05	2	117	2	28081256
Pubmed	Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.	ACACA ACACB	1.12e-05	2	117	2	26976583
Pubmed	The N-terminal domain of human holocarboxylase synthetase facilitates biotinylation via direct interaction with the substrate protein.	ACACB HLCS	1.12e-05	2	117	2	20085763
Pubmed	Hypoxia-induced TET1 facilitates trophoblast cell migration and invasion through HIF1α signaling pathway.	HIF1A TET1	1.12e-05	2	117	2	28808304
Pubmed	Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.	F8 DLC1	1.12e-05	2	117	2	24553346
Pubmed	AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation.	ACACA ACACB	1.12e-05	2	117	2	25001074
Pubmed	TET1 contributes to allergic airway inflammation and regulates interferon and aryl hydrocarbon receptor signaling pathways in bronchial epithelial cells.	TET1 AHR	1.12e-05	2	117	2	31089182
Pubmed	The subcellular localization of acetyl-CoA carboxylase 2.	ACACA ACACB	1.12e-05	2	117	2	10677481
Pubmed	Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.	ACACA ACACB	1.12e-05	2	117	2	24338821
Pubmed	HIF1α/TET1 Pathway Mediates Hypoxia-Induced Adipocytokine Promoter Hypomethylation in Human Adipocytes.	HIF1A TET1	1.12e-05	2	117	2	31935962
Pubmed	De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.	ACACA ACACB	1.12e-05	2	117	2	25282359
Pubmed	Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.	ACACA ACACB	1.12e-05	2	117	2	27693630
Pubmed	Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue.	ACACA ACACB	1.12e-05	2	117	2	32215608
Pubmed	USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2.	USP32 SMAD2	1.12e-05	2	117	2	32226309
Pubmed	Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor.	ACACA ACACB	1.12e-05	2	117	2	29772612
Pubmed	Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin.	ACACA ACACB	1.12e-05	2	117	2	29976587
Pubmed	Structure and regulation of acetyl-CoA carboxylase genes of metazoa.	ACACA ACACB	1.12e-05	2	117	2	15749055
Pubmed	AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis.	ACACA ACACB	1.12e-05	2	117	2	29433631
Pubmed	Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.	CEACAM5 MUC2	1.12e-05	2	117	2	21618511
Pubmed	Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.	ACACA ACACB	1.12e-05	2	117	2	36076520
Pubmed	Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion.	SEMA4B HIF1A	1.12e-05	2	117	2	24474252
Pubmed	Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.	F8 MUC2	1.12e-05	2	117	2	19411636
Pubmed	Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.	ACACA ACACB	1.12e-05	2	117	2	28290443
Pubmed	Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.	ACACA ACACB	1.12e-05	2	117	2	30244972
Pubmed	Deubiquitinating enzymes: a new class of biological regulators.	USP11 USP16 USP6	1.64e-05	15	117	3	9827704
Pubmed	Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice.	ITGA1 ITGA9 SMAD2	1.64e-05	15	117	3	26367869
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MIS18BP1 HIVEP1 USP11 TOPBP1 TACC2 SGO1 PIAS1 PPP4R3B ARID2 MACF1	3.12e-05	588	117	10	38580884
Pubmed	AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue.	ACACA ACACB	3.36e-05	3	117	2	34668531
Pubmed	AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.	ACACA ACACB	3.36e-05	3	117	2	30018077
Pubmed	MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.	HIF1A TET1	3.36e-05	3	117	2	35942521
Pubmed	Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels.	ACACA ACACB	3.36e-05	3	117	2	19846279
Pubmed	Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.	ACACA ACACB	3.36e-05	3	117	2	18031993
Pubmed	[Research on the mechanism of hypoxia promoting the migration of lung adenocarcinoma A549 cells].	HIF1A ACACA	3.36e-05	3	117	2	35634673
Pubmed	Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis.	ACACA ACACB	3.36e-05	3	117	2	20457939
Pubmed	Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism.	ACACA ACACB	3.36e-05	3	117	2	36417534
Pubmed	Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate.	ACACA ACACB	3.36e-05	3	117	2	18455495
Pubmed	Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.	ADAMTS5 SMAD2	3.36e-05	3	117	2	23531444
Pubmed	3, 3'-diindolylmethane, a natural aryl hydrocarbon receptor agonist, alleviates ulcerative colitis by enhancing "glycolysis-lactate-STAT3″ and TIP60 signals-mediated Treg differentiation.	HIF1A AHR	3.36e-05	3	117	2	37793204
Pubmed	A DNA-binding protein containing two widely separated zinc finger motifs that recognize the same DNA sequence.	HIF1A HIVEP1	3.36e-05	3	117	2	2106471
Pubmed	PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.	PIAS1 SMAD2	3.36e-05	3	117	2	24052079
Pubmed	Novel DNA binding by a basic helix-loop-helix protein. The role of the dioxin receptor PAS domain.	HIF1A AHR	3.36e-05	3	117	2	16520375
Pubmed	A HIF1A/miR-485-5p/SRPK1 axis modulates the aggressiveness of glioma cells upon hypoxia.	HIF1A SRPK1	3.36e-05	3	117	2	33722639
Pubmed	Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity.	HIF1A TET1	3.36e-05	3	117	2	29036334
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	3.36e-05	3	117	2	28877461
Pubmed	Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.	ACACA ACACB	3.36e-05	3	117	2	17521700
Pubmed	Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor.	HIF1A AHR	3.36e-05	3	117	2	8816435
Pubmed	Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.	ACACA ACACB	3.36e-05	3	117	2	31990961
Pubmed	The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.	ACACA ACACB	3.36e-05	3	117	2	27381369
Pubmed	Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.	ACACA ACACB	3.36e-05	3	117	2	17210641
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	3.36e-05	3	117	2	28768177
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ACACA ACACB PIAS1 SH3BP4 PRR12 NUP133	3.44e-05	180	117	6	35198878
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIS18BP1 HIVEP1 NACC1 TOPBP1 LRRC59 BTAF1 SGO1 PIAS1 PHC3 ARID2	4.14e-05	608	117	10	36089195
Pubmed	A large-scale candidate gene association study of age at menarche and age at natural menopause.	AMH DRD1 HIVEP1 HTR2C TENT5A TGFBR3 SMAD2	4.23e-05	275	117	7	20734064
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	HIVEP1 MLX USP11 ANKRD46 SYNE2 MYPN NUP133 MACF1 SMAD2	4.88e-05	497	117	9	23414517
Pubmed	Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.	HIF1A SMAD2	6.70e-05	4	117	2	23246962
Pubmed	A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis.	HIF1A AHR	6.70e-05	4	117	2	17413038
Pubmed	[Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis].	HIF1A CA10	6.70e-05	4	117	2	28537244
Pubmed	Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.	AHR NCOA1	6.70e-05	4	117	2	12024042
Pubmed	UV-Induced Reduction of ACVR1C Decreases SREBP1 and ACC Expression by the Suppression of SMAD2 Phosphorylation in Normal Human Epidermal Keratinocytes.	ACACA SMAD2	6.70e-05	4	117	2	33499275
Pubmed	Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis.	LRRC32 SMAD2	6.70e-05	4	117	2	28912269
Pubmed	Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.	HIF1A NCOA1	6.70e-05	4	117	2	10594042
Pubmed	Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.	ACACA ACACB	6.70e-05	4	117	2	24185692
Pubmed	Crystal structure of Spot 14, a modulator of fatty acid synthesis.	ACACA ACACB	6.70e-05	4	117	2	20952656
Pubmed	NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.	HIF1A AHR	6.70e-05	4	117	2	26350169
Pubmed	Hepatic malonyl-CoA synthesis restrains gluconeogenesis by suppressing fat oxidation, pyruvate carboxylation, and amino acid availability.	ACACA ACACB	6.70e-05	4	117	2	38447582
Pubmed	Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α.	HIF1A AHR	6.70e-05	4	117	2	26005855
Pubmed	cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation.	BIRC3 PIAS1	6.70e-05	4	117	2	23032264
Pubmed	Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2.	MUC2 SMAD2	6.70e-05	4	117	2	25166914
Pubmed	NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.	HIF1A NCOA1	6.70e-05	4	117	2	26287601
Pubmed	The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCRαβ⁺CD8αα⁺ cells.	HIF1A AHR	6.70e-05	4	117	2	23836150
Pubmed	Analysis of SNP profiles in patients with major depressive disorder.	DRD1 HTR2C	6.70e-05	4	117	2	15927089
Pubmed	Hypoxia: dual effect on the expression of transferrin receptor in human melanoma A375 cell line.	HIF1A BIRC3	6.70e-05	4	117	2	17927572
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MAN2B1 SRPK1 BTAF1 FHIP2A PIAS1 SH3BP4 PRR12 SMG8 GALNT6 PZP	7.21e-05	650	117	10	38777146
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACA ACACB TMEM94 CARMIL1 FLVCR1 MACF1 WDR13 SMAD2	9.32e-05	421	117	8	36976175
Pubmed	The Tre2 (USP6) oncogene is a hominoid-specific gene.	USP6 USP32	1.11e-04	5	117	2	12604796
Pubmed	A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor.	HIF1A AHR	1.11e-04	5	117	2	10671489
Pubmed	Cellular response to hypoxia involves signaling via Smad proteins.	HIF1A SMAD2	1.11e-04	5	117	2	12411310
Pubmed	Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss.	ACACA ACACB	1.11e-04	5	117	2	32694673
Pubmed	Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha.	HIF1A AHR	1.11e-04	5	117	2	11043581
Pubmed	Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse.	HIF1A AHR	1.11e-04	5	117	2	9545558
Pubmed	Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program.	ACACA ACACB	1.11e-04	5	117	2	37163372
Pubmed	Coenzyme A fuels T cell anti-tumor immunity.	HIF1A AHR	1.11e-04	5	117	2	34879240
Pubmed	The Activin Receptor, Activin-Like Kinase 4, Mediates Toxoplasma Gondii Activation of Hypoxia Inducible Factor-1.	HIF1A SMAD2	1.11e-04	5	117	2	30891432
Pubmed	TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism.	ACACA ACACB	1.11e-04	5	117	2	16794074
Pubmed	SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.	CEACAM5 TACC2 ITGA1	1.14e-04	28	117	3	32801337
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	HIVEP1 MYO5B ADGRB2 TACC2 CA10 MAPK8IP3 CYTIP RPIA NUP133	1.21e-04	560	117	9	21653829
Pubmed	Repurposing of the multiciliation gene regulatory network in fate specification of Cajal-Retzius neurons.	HTR2C SHISA2 WIF1	1.41e-04	30	117	3	37321213
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	AMH URI1 HTR2C ACACB USP11 HLCS ITGA9 SGO1 PPP4R3B	1.43e-04	573	117	9	28330616
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP11 USP16 USP6 USP32	1.66e-04	81	117	4	12838346
Pubmed	Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development.	HIF1A AHR	1.67e-04	6	117	2	11025203
Pubmed	TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.	HIF1A TET1	1.67e-04	6	117	2	25517638
Pubmed	Hypoxia switches TET1 from being tumor-suppressive to oncogenic.	HIF1A TET1	1.67e-04	6	117	2	37020036
Pubmed	Influence of dopaminergic and serotoninergic genes on working memory in healthy subjects.	DRD1 HTR2C	1.67e-04	6	117	2	20407490
Pubmed	Adamts5-/- Mice Exhibit Altered Aggrecan Proteolytic Profiles That Correlate With Ascending Aortic Anomalies.	ADAMTS5 SMAD2	1.67e-04	6	117	2	31366218
Pubmed	Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage.	URI1 AHR	1.67e-04	6	117	2	25453901
GeneFamily	Ubiquitin specific peptidases	USP11 USP16 USP6 USP32	1.10e-04	56	80	4	366
GeneFamily	Basic helix-loop-helix proteins	TFEC HIF1A MLX AHR NCOA1	1.27e-04	110	80	5	420
GeneFamily	Immunoglobulin like domain containing	CEACAM5 SLAMF1 IL18R1 CSF1R HMCN2	1.66e-03	193	80	5	594
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	LRRC32 SRPK1 SLAMF1 IL18R1 TGFBR3 TET1 MACF1 GALNT6	1.58e-05	210	112	8	GSM403995_500
CoexpressionAtlas	CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2	LRRC32 SRPK1 SLAMF1 IL18R1 TGFBR3 TET1 MACF1 GALNT6	2.51e-05	224	112	8	GSM403994_500
CoexpressionAtlas	CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1	LRRC32 SRPK1 SLAMF1 IL18R1 TGFBR3 TET1 MACF1 GALNT6 DISP1	7.69e-05	338	112	9	GSM403987_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4	ACACB ADGRB2 ITGA1 CTCFL CSF1R ACSBG1 AHR	8.20e-05	196	112	7	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4
ToppCell	Control-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	HIF1A SHISA2 TACC2 PGC DLC1 WIF1 AHR MACF1	4.41e-08	194	116	8	a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC32 ITGA1 ITGA9 F8 TGFBR3 DLC1 MACF1	8.64e-07	197	116	7	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC32 ITGA1 ITGA9 F8 TGFBR3 DLC1 MACF1	8.64e-07	197	116	7	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC32 ITGA1 ITGA9 F8 TGFBR3 DLC1 MACF1	8.94e-07	198	116	7	f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RTTN BTAF1 RBM39 TGFBR3 PHC3 SYNE2 MACF1	9.24e-07	199	116	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	HIF1A ITGA1 DLC1 MCTP1 SYNE2 MACF1 DISP1	9.56e-07	200	116	7	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TACC2 ADAMTS5 ITGA9 TGFBR3 WIF1 PLXNA4 PZP	9.56e-07	200	116	7	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	TACC2 ITGA1 ADAMTS5 ITGA9 TGFBR3 PLXNA4 PZP	9.56e-07	200	116	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TACC2 ITGA1 ADAMTS5 ITGA9 TGFBR3 PLXNA4 PZP	9.56e-07	200	116	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	BTAF1 RBM39 SYNE2 PKHD1 MACF1 CFAP57	1.48e-06	135	116	6	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	Control\|World / group, cell type (main and fine annotations)	CEACAM5 MYO5B TACC2 PGC DLC1 WIF1	5.24e-06	168	116	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC HTR2C TOPBP1 SGO1 MCOLN1 PTPDC1	7.29e-06	178	116	6	de6cd81e6d58e7687386df163471bf1901b9c0aa
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACACB LRRC32 ITGA9 F8 MCTP1 SYNE2	7.53e-06	179	116	6	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRD1 LRRC59 ADAMTS5 TGFBR3 ACSBG1 PKHD1	8.02e-06	181	116	6	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRD1 LRRC59 ADAMTS5 TGFBR3 ACSBG1 PKHD1	8.02e-06	181	116	6	3f50e61dc2a52d71a5801584617607e6246adcf2
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SHISA2 TACC2 PGC DLC1 WIF1 AHR	8.54e-06	183	116	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SHISA2 TACC2 PGC DLC1 WIF1 AHR	9.37e-06	186	116	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	SHISA2 PGC DLC1 MCTP1 WIF1 AHR	9.66e-06	187	116	6	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	BTAF1 ITGA1 RBM39 ARID2 SYNE2 MACF1	9.96e-06	188	116	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	SHISA2 TACC2 PGC DLC1 WIF1 AHR	9.96e-06	188	116	6	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TFEC BIRC3 SLAMF1 CYTIP CSF1R MCTP1	1.03e-05	189	116	6	35380ca9409206e82528bde4f3795057b015278a
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	LRRC32 ITGA1 F8 DLC1 MCTP1 SYNE2	1.06e-05	190	116	6	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SHISA2 TACC2 PGC DLC1 SYNE2 WIF1	1.12e-05	192	116	6	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC32 ITGA1 ITGA9 F8 DLC1 MACF1	1.16e-05	193	116	6	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA MYO5B TACC2 PGC DLC1 WIF1	1.19e-05	194	116	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA CARMIL1 TACC2 PGC DLC1 WIF1	1.19e-05	194	116	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRC32 BIRC3 SLAMF1 IL18R1 CYTIP PZP	1.23e-05	195	116	6	52f2fbb00058a43e269fc055b60695cea627732e
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ACACA MYO5B TACC2 PGC DLC1 WIF1	1.23e-05	195	116	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	LRRC32 ITGA1 ITGA9 F8 MCTP1 SYNE2	1.30e-05	197	116	6	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	TRPM6 HIF1A TACC2 DLC1 MCTP1 SYNE2	1.34e-05	198	116	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS5 ITGA9 TGFBR3 WIF1 PLXNA4 PZP	1.38e-05	199	116	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLC1 MCTP1 SYNE2 AHR MACF1 DISP1	1.41e-05	200	116	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	HIF1A LRRC32 SLAMF1 TGFBR3 MCTP1 SYNE2	1.41e-05	200	116	6	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLC1 MCTP1 SYNE2 AHR MACF1 DISP1	1.41e-05	200	116	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	ITGA1 ADAMTS5 ITGA9 TGFBR3 PLXNA4 PZP	1.41e-05	200	116	6	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	LRRC32 DLC1 MCTP1 SYNE2 MACF1 DISP1	1.41e-05	200	116	6	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	ADAMTS5 ITGA9 TGFBR3 WIF1 PLXNA4 PZP	1.41e-05	200	116	6	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ITGA1 MCTP1 SYNE2 AHR MACF1 DISP1	1.41e-05	200	116	6	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TACC2 ADAMTS5 ITGA9 TGFBR3 WIF1 PZP	1.41e-05	200	116	6	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	TACC2 ITGA1 ADAMTS5 TGFBR3 WIF1 PZP	1.41e-05	200	116	6	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TACC2 ADAMTS5 ITGA9 TGFBR3 PLXNA4 PZP	1.41e-05	200	116	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TACC2 ITGA1 ADAMTS5 TGFBR3 PLXNA4 PZP	1.41e-05	200	116	6	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	ITGA1 ADAMTS5 ITGA9 TGFBR3 PLXNA4 PZP	1.41e-05	200	116	6	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	LRRC32 DLC1 MCTP1 SYNE2 MACF1 DISP1	1.41e-05	200	116	6	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CNFN IL18R1 SH3BP4 CSF1R HMCN2	2.68e-05	134	116	5	917b8951dd4c870b6b92f2e73e02dac884330c30
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tox_(Neuron.Slc17a7.Syt6-Tox)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CNFN SERPINB11 PZP MUC2	3.01e-05	68	116	4	b8d472ff47312a8cc8ba60809947c82f4054d8de
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tox_(Neuron.Slc17a7.Syt6-Tox)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CNFN SERPINB11 PZP MUC2	3.01e-05	68	116	4	94acd088e39a17cd573aa3ad533b6634e3b7018d
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Syt6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CNFN SERPINB11 PZP MUC2	3.01e-05	68	116	4	89929e9e3a119f6eafef37a401e8fe2bd972452b
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC10A1 MYPN WIF1 PKHD1	3.57e-05	71	116	4	b0dbb059a7d05f825da608879b23aeebd6e9e61f
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SLC10A1 MYPN WIF1 PKHD1	3.57e-05	71	116	4	149504ce72da0730074ea436fc2034ce8cb585d5
ToppCell	COVID-19-Heart-Adipocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AMH ADAMTS5 TGFBR3 HMCN2 PLXNA4	5.04e-05	153	116	5	93958bd9c951222ba5b740d1cb83fd5d78a10e1e
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CNFN HLCS BIRC3 AHR RPA4	5.53e-05	156	116	5	0f2147abcf31a26ee5b2f4d8c5d72232612a33f0
ToppCell	BAL-Severe-Myeloid-cDC-cDC-cDC_6\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CNFN HLCS BIRC3 AHR RPA4	5.53e-05	156	116	5	cb87f12443fdc5538b856f765fcbac9406044e10
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TENT5A PGC PRR12 PKHD1 CFAP57	5.70e-05	157	116	5	4766f7d545bf2d775390589460677519cb92f4d5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA1 TGFBR3 SYNE2 TET1 PZP	5.87e-05	158	116	5	5775246e192629058ed89fb56031bdf4cbb9c15c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLAMF1 IL18R1 TGFBR3 SYNE2 PZP	6.23e-05	160	116	5	79e833c904c762434993b5ec9d5e3540e695fad3
ToppCell	BL-critical-LOC-Myeloid-Basophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ADGRB2 ITGA9 SLAMF1 DLC1 AHR	6.61e-05	162	116	5	25ec9df914445b4daae4fd28fd0e60b64797c46d
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SHISA2 TACC2 PGC DLC1 MCTP1	7.01e-05	164	116	5	b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SHISA2 TACC2 PGC DLC1 MCTP1	7.01e-05	164	116	5	3aea6207a011ad55a1aeb2ed9fb54d31b23694b5
ToppCell	normal_Lung-Epithelial_cells-Undetermined\|normal_Lung / Location, Cell class and cell subclass	CEACAM5 SHISA2 PGC DLC1 WIF1	7.01e-05	164	116	5	fa2dae15b38cb8f9642dbf00549beec8ee19e9bb
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs\|bone_marrow / Manually curated celltypes from each tissue	LRRC32 BIRC3 SLAMF1 SYNE2 CFAP57	7.21e-05	165	116	5	1ae1ad4e1fe19b6eefff0f9a03d58a384f169759
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BIRC3 SLAMF1 IL18R1 CYTIP SYNE2	7.42e-05	166	116	5	000faacc79b0bd279ddce4e692d801e7e2063ab6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYO5B F8 TGFBR3 SYNE2 PZP	7.63e-05	167	116	5	abc4ba308ca3be41b0da604f5d82579fd58dff7b
ToppCell	droplet-Heart-nan-3m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC MAN2B1 TENT5A CSF1R MCTP1	7.85e-05	168	116	5	a4eebc78babb9b5ef33065b0642793820195a613
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HIF1A CARMIL1 RBM39 USF3 MACF1	8.07e-05	169	116	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	Endothelial-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	AMH ITGA1 ADAMTS5 F8 TGFBR3	8.07e-05	169	116	5	8889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BIRC3 SLAMF1 IL18R1 CYTIP SYNE2	8.53e-05	171	116	5	e6dfbd2652b67577c8834c05348f62150637f348
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	SHISA2 BTAF1 RBM39 SYNE2 MACF1	8.53e-05	171	116	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BIRC3 SLAMF1 IL18R1 CYTIP SYNE2	8.53e-05	171	116	5	ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41
ToppCell	facs-Liver-Non-hepatocytes-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 SHISA2 SLAMF1 IL18R1 ACSBG1	8.77e-05	172	116	5	b440184f2d98d2f2d59566795f44fb79c0647ca4
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5B ADGRB2 ADAMTS5 ACSBG1 CFAP57	9.26e-05	174	116	5	4da79da7a09ee1e345102c5331675ebcdbe56171
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRC32 ITGA9 F8 TGFBR3 PZP	9.51e-05	175	116	5	90302e8a44858ef3b2a165b88284d4788d591a99
ToppCell	droplet-Fat-Mat-18m-Hematologic-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTTN BBS2 IL18R1 ACSBG1 GALNT6	9.77e-05	176	116	5	867936a20f73f638055c19c8d88834aa2cc657cf
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2B1 TENT5A IL18R1 GALNT6 POLN	9.77e-05	176	116	5	8e4600efeea095a92178cfd26d7c58db7dfc0c80
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 MAN2B1 TENT5A SGO1 KYAT3	9.77e-05	176	116	5	1f8d5a48fedbb4c86272c9b5a0f1ef573350357b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPP4R3B TGFBR3 USF3 SYNE2 MACF1	1.00e-04	177	116	5	d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPP4R3B TGFBR3 USF3 SYNE2 MACF1	1.00e-04	177	116	5	f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_activated\|COVID-19_Mild / Disease group, lineage and cell class	PPP4R3B TGFBR3 USF3 SYNE2 MACF1	1.00e-04	177	116	5	6978a22fef40c8b455342373abe7593f5ede0fa4
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	PPP4R3B TGFBR3 USF3 SYNE2 MACF1	1.00e-04	177	116	5	936ab2b180a052387124f68d0c7f41c0b164e748
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PPP4R3B TGFBR3 USF3 SYNE2 MACF1	1.00e-04	177	116	5	d5aeda113afaa2425874394610344570c9078478
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BIRC3 SLAMF1 IL18R1 CYTIP GALNT6	1.00e-04	177	116	5	9828504591599619649d41a78daf7c052729c669
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEACAM5 MYO5B CARMIL1 ITGA9 PKHD1	1.00e-04	177	116	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEACAM5 MYO5B CNFN CARMIL1 PKHD1	1.03e-04	178	116	5	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A IL18R1 GALNT6 POLN DISP1	1.03e-04	178	116	5	cc0382b0ee1e6c76522e2c86ad1425c45debab5d
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEACAM5 MYO5B CNFN CARMIL1 PKHD1	1.03e-04	178	116	5	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|343B / Donor, Lineage, Cell class and subclass (all cells)	BIRC3 CCDC168 FHIP2A SLAMF1 IL18R1	1.06e-04	179	116	5	c09c3eed43d1aa3b7aa8f3021e6f2737840cde16
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRC32 ITGA1 F8 SYNE2 MACF1	1.09e-04	180	116	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ACACA TACC2 PGC DLC1 WIF1	1.09e-04	180	116	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TACC2 ADAMTS5 ITGA9 TGFBR3 PLXNA4	1.11e-04	181	116	5	25915e2500430a902db37d79a749ce2990b69810
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TMEM94 TGFBR3 SYNE2 TET1 PZP	1.11e-04	181	116	5	12ff56fa2949c8d53360cdf2cacfd326e65b54aa
ToppCell	COVID-19-T_cells-Tregs\|COVID-19 / group, cell type (main and fine annotations)	BIRC3 SLAMF1 IL18R1 CYTIP SYNE2	1.11e-04	181	116	5	534659cf754326c6a73c0daa30e9d610612a0292
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA1 ITGA9 HMCN2 WIF1 MACF1	1.11e-04	181	116	5	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEACAM5 MYO5B CNFN TENT5A PKHD1	1.14e-04	182	116	5	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	facs-Skin-Anagen-3m-Epithelial-Basal_IFE\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4B TENT5A FLVCR1 TGFBR3 CFAP57	1.14e-04	182	116	5	22d6f4790950508e8aa27e02a8133af5f53f13c8
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC TENT5A TOPBP1 ITGA1 CSF1R	1.14e-04	182	116	5	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ABCB5 BIRC3 IL18R1 ACSBG1 AHR	1.14e-04	182	116	5	6bd48c5d60a259719f65cacee4b8135247e78fa9
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS5 ITGA9 TGFBR3 WIF1 PLXNA4	1.17e-04	183	116	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CCDC168 FHIP2A USF3 NUP133 WDR13	1.17e-04	183	116	5	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TFEC SEMA4B TENT5A MCTP1 MACF1	1.17e-04	183	116	5	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ABCB5 CA10 SLAMF1 IL18R1 CYTIP	1.20e-04	184	116	5	3e9d75af578297950e469f23fb2d28393a2feef8
Disease	Chronobiology Disorders	SGO1 AHR	4.12e-05	3	110	2	C0236811
Disease	Circadian Rhythm Disorders	SGO1 AHR	4.12e-05	3	110	2	C0813142
Disease	Psychogenic Inversion of Circadian Rhythm	SGO1 AHR	4.12e-05	3	110	2	C0887800
Disease	Malignant neoplasm of breast	HIF1A HLCS TACC2 XRCC3 ITGA9 SLAMF1 MCOLN1 CSF1R SYNE2 NUP133 AHR NCOA1 MACF1 GPR45	4.69e-05	1074	110	14	C0006142
Disease	Benign Neoplasm	NACC1 DLC1 CSF1R AHR	1.24e-04	68	110	4	C0086692
Disease	Neoplasms	NACC1 DLC1 CSF1R AHR	1.24e-04	68	110	4	C0027651
Disease	muscular disease (implicated_via_orthology)	ACACA ACACB	1.37e-04	5	110	2	DOID:0080000 (implicated_via_orthology)
Disease	Intestinal Diseases	MYO5B SGO1	3.80e-04	8	110	2	C0021831
Disease	IGF-1 measurement	DRD1 ACACB CARMIL1 PIAS1 MAPK8IP3 PHC3 SYNE2 ASTN1	4.97e-04	488	110	8	EFO_0004627
Disease	peak expiratory flow	CARMIL1 ITGA1 ADAMTS5 TGFBR3 PTPDC1 DLC1 MYPN NCOA1	5.67e-04	498	110	8	EFO_0009718
Disease	Congenital Heart Defects	HIF1A TMEM94 AHR	5.97e-04	44	110	3	C0018798
Disease	Pancreatic Ductal Adenocarcinoma	ACACB ABCB5	7.41e-04	11	110	2	C1335302
Disease	refractive error, age at onset, Myopia	DRD1 MYO5B KCNA4 ARID2 PZP	7.98e-04	193	110	5	EFO_0004847, HP_0000545, MONDO_0004892
Disease	hepatocellular carcinoma (is_marker_for)	HIF1A BIRC3 IL18R1 CSF1R ARID2 TET1	9.45e-04	301	110	6	DOID:684 (is_marker_for)
Disease	hepcidin:ferritin ratio	CARMIL1 LRRC32 TACC2	1.15e-03	55	110	3	EFO_0007901
Disease	Malignant Neoplasms	NACC1 DLC1 CSF1R AHR	1.37e-03	128	110	4	C0006826
Disease	renal cell carcinoma (is_marker_for)	HIF1A BIRC3 CSF1R SMAD2	1.37e-03	128	110	4	DOID:4450 (is_marker_for)
Disease	unipolar depression, cognitive function measurement	ADAMTS5 CPXM1	1.40e-03	15	110	2	EFO_0003761, EFO_0008354
Disease	hematocrit	HIVEP1 ACACA FLVCR1 HLCS ITGA1 PRR12 KCNA4 ACSBG1 TMLHE ARID2 PKHD1	1.41e-03	1011	110	11	EFO_0004348
Disease	non-high density lipoprotein cholesterol measurement	HIVEP1 NACC1 CARMIL1 ITGA1 KCNA4 DLC1 CSF1R SYNE2 AHR	1.42e-03	713	110	9	EFO_0005689
Disease	Intellectual Disability	TMEM94 RTTN FHIP2A MAPK8IP3 PRR12 MACF1 ASTN1	1.46e-03	447	110	7	C3714756
Disease	Global developmental delay	TMEM94 FHIP2A MAPK8IP3 PRR12	1.57e-03	133	110	4	C0557874
Disease	pro-hydroxy-pro measurement	TRPM6 MCTP1	1.60e-03	16	110	2	EFO_0021132
Disease	lung non-small cell carcinoma (is_implicated_in)	HIF1A TENT5A BIRC3 CSF1R	1.85e-03	139	110	4	DOID:3908 (is_implicated_in)
Disease	Neoplasms, Experimental	HIF1A URI1 AHR	1.94e-03	66	110	3	C0027659
Disease	magnesium measurement	TRPM6 CCDC168 DLC1	1.94e-03	66	110	3	EFO_0004845
Disease	PR interval	CARMIL1 ABCB5 ITGA9 DLC1 ARID2 SYNE2 MACF1	2.59e-03	495	110	7	EFO_0004462
Disease	intraocular pressure measurement	TFEC ADGRB2 ST7L MAPK8IP3 DLC1 PKHD1 CPXM1	3.02e-03	509	110	7	EFO_0004695

Protein segments in the cluster

Peptide	Gene	Start	Entry
YTQNFISCNQPVLPQ	AHR	696	P35869
LLINNNNSSQFTCGV	ADGRB2	186	O60241
QQCVAISIQQELYSP	CTCFL	131	Q8NI51
LPGQTYDATQQCNLT	ADAMTS5	486	Q9UNA0
LVQTNTTNYQNCTQS	ABCB5	81	Q2M3G0
SCINANNINYITEGI	GOT1L1	381	Q8NHS2
IPNITVNNSGSYTCQ	CEACAM5	286	P06731
FVNNTTCVLNDPNFV	HTR2C	201	P28335
QNIPACTSTVSQGQQ	ARID2	806	Q68CP9
QVQEQCPNITRIYSI	CPXM1	311	Q96SM3
ASNITSVLCQFPSQQ	ACACA	926	Q13085
SVLCQFPSQQIANIL	ACACA	931	Q13085
PSCRFVQSLNSVNNL	BIRC3	91	Q13489
CPATNNAIETVSINN	DRD1	351	P21728
VNDSSQTNVPLLQAC	ANKRD46	6	Q86W74
HQCSPTTSSFVQIQN	DISP1	1296	Q96F81
LNPAQVVLFSQQNSS	ASTN1	441	O14525
SCLIPQYNQEASVLQ	POLN	116	Q7Z5Q5
FSQQLNSNGCITQQV	PZP	286	P20742
ASVQPLATQCFQLSN	RBM39	416	Q14498
NLQSLINNEIPDCYT	MCOLN1	241	Q9GZU1
DLQTIVPTCQQQDFS	MLX	151	Q9UH92
NITSVLCQFPSQQIA	ACACB	1071	O00763
DLILCQLTVPNFSNQ	NUP133	401	Q8WUM0
QTQTQTISYPGCLAQ	OR1F12P	86	Q8NHA8
NIGESNLNVLYNCTV	IL18R1	286	Q13478
LQNPYCKNVQFQTQS	MCTP1	441	Q6DN14
QNTNAETLSTNCIPI	MIS18BP1	281	Q6P0N0
INSQCVNTSQAVQDP	MAGEE2	51	Q8TD90
NQPGTVVDQFTVCNA	MAPK8IP3	791	Q9UPT6
LQQQPLCTSVNTIYD	LRRC59	271	Q96AG4
ATVIYNTKNSQPQCI	HIF1A	321	Q16665
NVSVNQTALLPCQAD	HMCN2	3696	Q8NDA2
QITPLNDNVTIFCNI	NCR3LG1	36	Q68D85
VYQVSFSPQDNTQVC	CFAP57	156	Q96MR6
GFNVTNSNPTICIND	HLCS	601	P50747
VQTCNEPLTTTNNVN	PLXNA4	101	Q9HCM2
CPNSQVFLYNLTTCQ	MUC2	661	Q02817
CQNNPSEIIQSTYQE	FAM214A	586	Q32MH5
SQYVCQQTGLQIPQL	MICOS13	56	Q5XKP0
RSQQQEPLVCASYQS	KRT33A	91	O76009
ACTTRISPNTSQQNF	F8	1311	P00451
SVLIPETYQANNCQG	AMH	476	P03971
QPYSTLVNNSECVAN	PTPDC1	11	A2A3K4
NTICPDNYQTAQLLA	PPP4R3B	531	Q5MIZ7
QVVNSIAPVQECSTQ	ITGA1	156	P56199
VINSVCVQPELQNNT	PHC3	741	Q8NDX5
RIQPSTVYVCNENQS	GPR45	356	Q9Y5Y3
QPLRNTSFTCQNEQA	MACF1	2166	Q9UPN3
QTQDQSILYAGCVTQ	OR1J4	86	Q8NGS1
LNQCNLQTQTVTVNP	PTPN21	306	Q16825
QAQNQSITYTGCLTQ	OR7G1	86	Q8NGA0
SCNSIEAFQTASQPQ	LRRC32	226	Q14392
QNVQLCSTILNVAFP	SLC10A1	261	Q14973
QQPVNCLNVTTCFSF	ITGA9	486	Q13797
SDPICTNSLQVQRQF	EBLN1	151	P0CF75
PTFQQICSFLQEQAQ	CSF1R	901	P07333
IQNAPFQVCFTSLRN	BBS2	526	Q9BXC9
LTYPQVQQCSIQQSL	BTAF1	501	O14981
PEAQQTLFSINQSCL	GALNT6	76	Q8NCL4
QQPNQCCVLVYTSGT	ACSBG1	271	Q96GR2
PNTQNDTNLLACNIS	FLVCR1	261	Q9Y5Y0
EIQSYRPQNQNACSS	CYTIP	91	O60759
TFCQQLNISICPLSQ	MAN2B1	491	O00754
QQPTQAAVCAANIVS	CARMIL1	996	Q5VZK9
YQCSRSQESLNQNQP	CCDC168	271	Q8NDH2
SVVCPNQDYNLVNSL	FHIP2A	251	Q5W0V3
LQANFIVCISAQQNS	CA10	11	Q9NS85
QQNTIYTCATPLQEA	KYAT3	306	Q6YP21
QSINCLFTVPANQAF	SMG8	321	Q8ND04
QENLNLVCIPTSFQA	RPIA	121	P49247
ELQFQQLSLPQFCVS	RTTN	371	Q86VV8
NTACLQEPQSVSILQ	RARS2	486	Q5T160
EPFSGQVNSQLNCSV	URI1	276	O94763
TAQVLSFLEPCTQQV	SPATA31C2	631	B4DYI2
DQEAILTQFCVQTPQ	SH3BP4	596	Q9P0V3
IPFQQYQQVSQRAEC	SYNE2	3761	Q8WXH0
CNNNNRSYSNIPVTS	NCOA1	526	Q15788
QAQAQSINYTGCLTQ	OR7G3	86	Q8NG95
CEQVQFQPNTVNTLA	SEMA4B	596	Q9NPR2
QQTVEPAQNQEICSS	SGO1	106	Q5FBB7
IYICTVSNPISNNSQ	SLAMF1	206	Q13291
PTNFSVLNCQQATQI	SHISA2	221	Q6UWI4
CTFQPVNNNLTVVGN	WDR13	266	Q9H1Z4
SNQTNVVCQTDLLPV	PKHD1	976	P08F94
CNGVIEVINYTQNSN	SRPK1	356	Q96SB4
ETCFAFALTPQQVQQ	PIAS1	166	O75925
LATCQSYSPDQLQGQ	PRR12	491	Q9ULL5
FSQINQPDSNCTLSI	SERPINB11	91	Q96P15
PSLNSVSLQINCQSV	DLC1	1011	Q96QB1
NVLVFQQPGFNCSSI	TET1	821	Q8NFU7
QASSQECINVLLQYG	AGAP5	666	A6NIR3
TSQPQCATTSCYQTQ	CNFN	6	Q9BYD5
PQTCNQVSLNTSQSE	UHRF1BP1L	741	A0JNW5
IITVNACSQSDQLNP	TRPM6	1596	Q9BX84
NEVQYCSSNQLGQVV	USP16	121	Q9Y5T5
VVPCNVNQLLSSTVF	RPA4	46	Q13156
FLVNCNSIQNLPSLT	PGC	306	P20142
LSLSQDQQNPSCIQF	TMEM94	556	Q12767
SDSAIFVQSPNCNQR	SMAD2	351	Q15796
SNPSKQVFVDQCYQL	ZNF654	311	Q8IZM8
TIYRQSQQCQHQSPQ	ST7L	266	Q8TDW4
QTPQNAIFFKTCQQA	WIF1	166	Q9Y5W5
CVQLSISQPANSQTA	USF3	726	Q68DE3
NNFVTPALRQTEVQC	USF3	1406	Q68DE3
NAASQESCQQPVGAY	TACC2	326	O95359
TQLQQACAQVPTSRA	nan	171	Q6ZWC4
QNSVDYCQQLTVSQG	TFEC	256	O14948
ASQITCENELVQTQP	THAP10	141	Q9P2Z0
IAQVQPVFTCQQQTY	TENT5A	421	Q96IP4
CPTQYSELQVDIQNL	TOPBP1	1166	Q92547
IYQQAQVPSVDCQSF	TMLHE	156	Q9NVH6
NSALQCLSNVPQLTE	USP11	321	P51784
SNSSSTNVFPVQQLC	HIVEP1	1496	P15822
SSAFQSPVLCINQVT	XRCC3	246	O43542
SIQCVSNTQPLTQYF	USP6	546	P35125
NSSIQCVSNTQPLTQ	USP32	746	Q8NFA0
NCSLQQVRNPSSFQE	TGFBR3	571	Q03167
QTQLTQNAVSCPYLP	KCNA4	576	P22459
QQTFCQTLLLSPEAQ	MYO5B	1376	Q9ULV0
AAVQPQSFQQILSFC	NACC1	71	Q96RE7
ATIQQCQSPTNYLQG	MYPN	411	Q86TC9